Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Refractec Viewpoint Hyperopia Approval Limited To Temporary Treatment

Apr 22 2002

Related Content

Sunrise's Hyperion Laser Gains FDA Approval For Hyperopia

Jul 03 2000

Refractec ViewPoint Approval Should Reflect Lack Of Long-Term Data – Panel

Dec 03 2001

Refractec ViewPoint Comparative Claims Questioned During Panel Review

Dec 10 2001

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window